Malaria: New Vaccines for Old?
نویسنده
چکیده
Detailed analyses of the 5500 genes revealed by the complete Plasmodium genome sequence are yielding new candidate parasite antigens and strategies that may contribute to a successful vaccine against malaria in the coming decade.
منابع مشابه
First DNA malaria vaccine on trial in Africa
Scientists from Oxford have taken another step along the frustrating route to an effective malaria vaccine. This autumn, Vasee Moorthy of Oxford University’s Department of Clinical Medicine, working with scientists at the Medical Research Council’s Laboratories in the Gambia, began trials of new DNA-based vaccines against the malaria parasite Plasmodium falciparum. The vaccines, developed by Ad...
متن کاملDrugs for malaria: something old, something new, something borrowed
Malaria was estimated to cause 800,000 deaths and 225 million cases worldwide in 2010. Worryingly, the first-line treatment currently relies on a single drug class called artemisinins, and there are signs that the parasite is becoming resistant to these drugs. The good news is that new technology has given us new approaches to drug discovery. New drugs generated this way are probably 10-15 year...
متن کاملCurrent status of malaria and potential for control.
Malaria remains one of the world's worst health problems with 1.5 to 2.7 million deaths annually; these deaths are primarily among children under 5 years of age and pregnant women in sub-Saharan Africa. Of significance, more people are dying from malaria today than 30 years ago. This review considers the factors which have contributed to this gloomy picture, including those which relate to the ...
متن کاملVaccination against Mosquito Borne Viral Infections: Current Status
Mosquito borne infectious diseases are among important group of diseases worldwide. Vaccination is available for some tropical mosquito-borne diseases, especially for Japa-nese encephalitis virus infection and yellow fever. There are also several attempts to develop new vaccines for the other mosquito-borne diseases such as malaria, dengue infection and West Nile virus infection. In this articl...
متن کاملImplications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
BACKGROUND Malaria is a leading cause of morbidity and mortality, with approximately 225 million clinical episodes and >1.2 million deaths annually attributed to malaria. Development of a highly efficacious malaria vaccine will offer unparalleled possibilities for disease prevention and remains a key priority for long-term malaria control and elimination. DISCUSSION The Malaria Vaccine Techno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cell
دوره 124 شماره
صفحات -
تاریخ انتشار 2006